Ian Patel

Title: Ian Patel: Innovator in Asymmetric Synthesis

Introduction

Ian Patel is a notable inventor based in Bristol, GB. He has made significant contributions to the field of chemistry, particularly in the area of asymmetric synthesis. With a total of 3 patents to his name, Patel's work is recognized for its innovative approaches and practical applications.

Latest Patents

One of Ian Patel's latest patents is titled "Process for asymmetric synthesis of substituted 1,4-dihydropyridines." This patent describes a method for reacting a vinylogous amide with an α,β-unsaturated ketone in the presence of a silicon compound to form a 1,5-diketone, which is then converted to a 1,4-dihydropyridine. The process involves preparing an asymmetric vinylogous amide by reacting a 1,3-cyclohexanedione with a substantially homo-chiral phenylethylamine. The reaction results in the formation of an asymmetric 1,5-diketone, which is subsequently transformed into an asymmetric substituted 1,4-dihydropyridine.

Career Highlights

Ian Patel is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative pharmaceutical solutions. Patel's expertise in asymmetric synthesis has positioned him as a valuable asset in the research and development sector.

Collaborations

Throughout his career, Ian Patel has collaborated with several talented individuals, including Ian Ashworth and Daniel Levin. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Ian Patel's contributions to the field of asymmetric synthesis highlight his innovative spirit and dedication to advancing pharmaceutical science. His patents and collaborations reflect a commitment to improving healthcare through scientific discovery.